obagi skintrinsiq antioxidant protocol

Generic: avobenzone, homosalate, octisalate, octocrylene, and oxybenzone

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name obagi skintrinsiq antioxidant protocol
Generic Name avobenzone, homosalate, octisalate, octocrylene, and oxybenzone
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-907
Product ID 62032-907_3cabac1e-2e2d-4e3c-ab1e-5ae59f8dc4f9
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M020
Listing Expiration 2026-12-31
Marketing Start 2021-08-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032907
Hyphenated Format 62032-907

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi skintrinsiq antioxidant protocol (source: ndc)
Generic Name avobenzone, homosalate, octisalate, octocrylene, and oxybenzone (source: ndc)
Application Number M020 (source: ndc)

Resolved Composition

Strengths
  • 3 %
  • 8 %
  • 5 %
  • 2.79 %
source: label
Packaging
  • 1 KIT in 1 BOX (62032-907-07) * 1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER * 1 BOTTLE, PUMP in 1 CARTON / 30 mL in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-050-54) / 48 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

62032-907-07 1 KIT in 1 BOX (62032-907-07) * 1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER * 1 BOTTLE, PUMP in 1 CARTON / 30 mL in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-050-54) / 48 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi Skintrinsiq Antioxidant Protocol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "3cabac1e-2e2d-4e3c-ab1e-5ae59f8dc4f9", "openfda": {"spl_set_id": ["495bc176-b292-448f-a5a6-00de2e475e54"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 BOX (62032-907-07)  *  1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER *  1 BOTTLE, PUMP in 1 CARTON / 30 mL in 1 BOTTLE, PUMP *  1 TUBE in 1 CARTON (62032-050-54)  / 48 g in 1 TUBE *  59 mL in 1 BOTTLE, PLASTIC *  60 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62032-907-07", "marketing_start_date": "20210801"}], "brand_name": "Obagi Skintrinsiq Antioxidant Protocol", "product_id": "62032-907_3cabac1e-2e2d-4e3c-ab1e-5ae59f8dc4f9", "dosage_form": "KIT", "product_ndc": "62032-907", "generic_name": "AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi Skintrinsiq Antioxidant Protocol", "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210801", "listing_expiration_date": "20261231"}